Ruth Franken focuses on the EU and Dutch Life Sciences industry (medicinal products, medical devices and food). She has extensive experience in advising pharmaceutical companies on EU and Dutch regulatory matters, e.g. how to obtain market access through marketing authorisation procedures (general requirements, clinical trials, regulatory data protection and exclusivity rights, etc.), pricing and reimbursement (procedures, financial arrangements) and how to be compliant in a fast moving and changing environment (interactions with healthcare professionals, compliance issues, audits, legal procedures, etc.).